America must protect its drug supply from China
The Chinese Communist Party controls America’s drug supply. Policymakers must reduce our nation’s reliance on China, and recently introduced legislation offers a good start.
TL;DR
- The U.S. imports a significant portion of its drug manufacturing materials, with a substantial amount originating from China, directly or indirectly.
- China's control over pharmaceutical supplies poses a national security risk, as it can be used for economic coercion, as evidenced by past trade disputes and the COVID-19 crisis.
- Senator Tom Cotton's "Securing America’s Drug Supply from Communist China Act" aims to screen companies for CCP ties and remove affected drugs.
- Reducing reliance on China requires encouraging domestic manufacturing and strengthening supply chains with allied nations.
- Unlike during the Cold War, the U.S. now depends on its main adversary for essential medicines, a vulnerability that must be addressed.